“Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.”, PLoS One, vol. 14, no. 9, p. e0222178, 2019.
, “Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.”, Vaccine, vol. 37, no. 36, pp. 5161-5170, 2019.
, “Strength through Structure: Defending a Structured Approach to Contraceptive Mandates in Clinical Research.”, Ethics Hum Res, vol. 41, no. 3, pp. 33-35, 2019.
, “Stroke Version 2.0 Common Data Element (CDE) Review: Updates to the National Institute of Neurological Disorders and Stroke (NINDS) CDEs for Stroke”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
, “Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.”, Vaccines (Basel), vol. 8, no. 1, 2019.
, “Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with”, Lancet Haematol, vol. 6, no. 3, pp. e132-e143, 2019.
, “Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.”, Am J Med Genet C Semin Med Genet, vol. 181, no. 4, pp. 571-581, 2019.
, “Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.”, Circulation, vol. 140, no. 8, pp. 658-664, 2019.
, “Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.”, Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
, , “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Multiple Sclerosis (MS) Common Data Element (CDE) Recommendations: 2018 MS Oversight Committee (OC) Review”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
, “A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials.”, Sci Transl Med, vol. 11, no. 507, 2019.
, “ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S79-S88, 2018.
, “Air pollution exposure during pregnancy: maternal asthma and neonatal respiratory outcomes.”, Ann Epidemiol, vol. 28, no. 9, pp. 612-618.e4, 2018.
, “Ambient air pollution and semen quality.”, Environ Res, vol. 163, pp. 228-236, 2018.
, “Ambient air pollution and the risk of pregnancy loss: a prospective cohort study.”, Fertil Steril, vol. 109, no. 1, pp. 148-153, 2018.
, “Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.”, Blood Adv, vol. 2, no. 15, pp. 1882-1888, 2018.
, “Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.”, Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
, “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”, Ophthalmology, vol. 125, no. 4, pp. 512-521, 2018.
, “Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.”, Biol Blood Marrow Transplant, vol. 24, no. 6, pp. 1274-1280, 2018.
, “Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.”, Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
, “Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.”, Epilepsy Behav, vol. 84, pp. 10-14, 2018.
, “CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
, “Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.”, Lancet Infect Dis, vol. 18, no. 10, pp. 1097-1107, 2018.
, “Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S33-S39, 2018.
,